ArticleSystematic reviews2025
Quality improvement needed for rapid review reports: a literature quality assessment based on Cochrane RR evidence-based methodology.
Article in Systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Publication Characteristics and Reporting Quality of GBD-Derived Burden of Disease Studies: A Cross-Sectional Analysis of Lung Cancer.Journal of evidence-based medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe aim of this study was to assess the reporting quality of rapid reviews (RRs) against the Cochrane Rapid Reviews Methodological Guidance to identify areas for improvement.
methodsA literature quality assessment was conducted through systematic searches in PubMed, the Cochrane Library, and Web of Science until February 28, 2023. An expert guided the search strategy, and the reporting quality of RRs was evaluated. Descriptive statistics were used to summarize reporting quality, and subgroup analyses were performed to examine differences between groups. Categorical variables were compared using the chi-square (χ
resultsAmong the 112 rapid reviews analyzed, fewer than 50% fully reported four key methodological components: topic refinement with stakeholders, eligibility criteria co-definition, risk of bias assessment tools, and protocol/software reporting. Reports published after 2021 demonstrated slightly higher overall quality compared to those published before 2020, with significant improvements in protocol development (Item 2: χ
conclusionsWhile RR quality is improving post-2021, critical gaps persist in stakeholder engagement and protocol transparency. Mandatory adoption of Cochrane guidelines-particularly protocol registration (Item23) and dual data extraction (Item17)-should be prioritized in journal submission policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.